161 results on '"Xie, Xiaoliang Sunney"'
Search Results
2. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
3. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
4. Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study
5. A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
6. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
7. Superresolution imaging reveals spatiotemporal propagation of human replication foci mediated by CTCF-organized chromatin structures
8. Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants
9. Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
10. Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
11. Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents Infection of Omicron lineages
12. Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages
13. Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86
14. Single-cell bisulfite-free 5mC and 5hmC sequencing with high sensitivity and scalability
15. Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
16. Noninvasive preimplantation genetic testing for aneuploidy in spent medium may be more reliable than trophectoderm biopsy
17. Simultaneous single-cell chromatin architecture and gene expression sequencing by LiMCA
18. Bayesian model for accurate MARSALA (mutated allele revealed by sequencing with aneuploidy and linkage analyses)
19. Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86
20. Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
21. Figure S1-S6 from Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells
22. Table S1 from Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells
23. Table S2-S11 from Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells
24. Opposing, spatially-determined epigenetic forces impose restrictions on stochastic olfactory receptor choice
25. Single cell genomics to study DNA and chromosome changes in human gametes and embryos
26. Round-Trip Journey of a Physical Chemist.
27. Safety and Effectiveness of SA58 Nasal Spray against COVID-19 Infection in Medical Personnel:An Open-label, Blank-controlled Study
28. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
29. Correlated gene modules uncovered by high-precision single-cell transcriptomics
30. Rational identification of potent and broad sarbecovirus-neutralizing antibody cocktails from SARS convalescents
31. Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
32. Characterization of the enhanced infectivity and antibody evasion of Omicron BA.2.75
33. Characterizations of enhanced infectivity and antibody evasion of Omicron BA.2.75
34. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
35. Circular RNA vaccines against SARS-CoV-2 and emerging variants
36. Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study
37. Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron
38. Omicron BA.2 specifically evades broad sarbecovirus neutralizing antibodies
39. Structural and functional characterizations of altered infectivity and immune evasion of SARS-CoV-2 Omicron variant
40. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
41. Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine
42. False Coronavirus Disease 2019 Cases due to Contamination by Inactivated Virus Vaccine
43. A third dose of inactivated vaccine augments the potency, breadth, and duration of anamnestic responses against SARS-CoV-2
44. Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants
45. Single Molecules Meet Genomics: Pinpointing Precision Medicine
46. SISGR: Room Temperature Single-Molecule Detection and Imaging by Stimulated Emission Microscopy
47. Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants
48. False Coronavirus Disease 2019 Cases due to Contamination by Inactivated Virus Vaccine.
49. CTCF-mediated Chromatin Structures Dictate the Spatio-temporal Propagation of Replication Foci: Supplementary Materials
50. Diseases Have No Borders, Neither Should Research!
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.